PONTI, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 15.047
EU - Europa 6.931
AS - Asia 1.512
SA - Sud America 34
Continente sconosciuto - Info sul continente non disponibili 13
AF - Africa 9
OC - Oceania 7
Totale 23.553
Nazione #
US - Stati Uniti d'America 14.761
GB - Regno Unito 2.826
IT - Italia 1.467
SE - Svezia 810
CN - Cina 640
DE - Germania 602
UA - Ucraina 429
HK - Hong Kong 333
TR - Turchia 305
FI - Finlandia 245
CA - Canada 217
BG - Bulgaria 163
FR - Francia 160
MX - Messico 66
RU - Federazione Russa 48
VN - Vietnam 45
SG - Singapore 43
ID - Indonesia 38
IN - India 35
IE - Irlanda 29
BE - Belgio 24
NL - Olanda 24
LT - Lituania 20
JP - Giappone 18
BR - Brasile 17
MY - Malesia 16
RO - Romania 13
CH - Svizzera 12
ES - Italia 11
KR - Corea 11
EU - Europa 10
CL - Cile 8
IR - Iran 8
LU - Lussemburgo 8
PT - Portogallo 7
AU - Australia 6
NO - Norvegia 6
PE - Perù 5
PL - Polonia 5
LB - Libano 4
NG - Nigeria 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AT - Austria 3
BD - Bangladesh 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
SI - Slovenia 3
AR - Argentina 2
HU - Ungheria 2
IL - Israele 2
MD - Moldavia 2
PH - Filippine 2
RS - Serbia 2
SA - Arabia Saudita 2
SD - Sudan 2
TH - Thailandia 2
BH - Bahrain 1
BY - Bielorussia 1
BZ - Belize 1
CR - Costa Rica 1
EG - Egitto 1
FK - Isole Falkland (Malvinas) 1
GH - Ghana 1
GT - Guatemala 1
HR - Croazia 1
IQ - Iraq 1
JO - Giordania 1
KZ - Kazakistan 1
MA - Marocco 1
MO - Macao, regione amministrativa speciale della Cina 1
MT - Malta 1
NZ - Nuova Zelanda 1
SM - San Marino 1
VE - Venezuela 1
Totale 23.553
Città #
Fairfield 2.538
Southend 2.473
Woodbridge 1.578
Ashburn 1.198
Houston 1.155
Seattle 975
Chandler 923
Jacksonville 828
Cambridge 809
Wilmington 809
Dearborn 786
Ann Arbor 661
Nyköping 543
Hong Kong 330
Modena 272
Beijing 261
San Diego 206
Princeton 203
Ottawa 192
Izmir 188
Sofia 163
Eugene 155
Helsinki 111
Bremen 81
New York 78
London 77
Milan 73
Rome 64
Redwood City 54
Grafing 51
Dong Ket 44
Jakarta 37
Des Moines 34
Norwalk 34
Fremont 33
Boardman 30
Frankfurt am Main 30
Shanghai 28
Dublin 26
Hefei 22
Nanjing 22
San Mateo 21
Bologna 20
Dongguan 20
Hounslow 19
Kilburn 18
Buffalo 17
Falls Church 17
Guangzhou 17
Kunming 17
Chiswick 16
Parma 16
Brussels 15
Palermo 15
Phoenix 15
Turin 15
Tulare 14
Cagliari 13
Padova 12
Genova 11
Jinan 11
Saint Petersburg 11
Toronto 11
Verona 11
Auburn Hills 10
Augusta 10
Mumbai 10
Naples 10
Napoli 10
Bari 9
Wuhan 9
Indiana 8
Salerno 8
Segrate 8
Waanrode 8
Chieti 7
Los Angeles 7
Nanchang 7
Ansbach 6
Castelnuovo Rangone 6
Catania 6
Ceranova 6
Fuzhou 6
Genoa 6
Leawood 6
Mountain View 6
Reggio Emilia 6
Trieste 6
Atlanta 5
Chicago 5
Dallas 5
Florence 5
Grosseto 5
Kemerovo 5
Lima 5
Niterói 5
Novara 5
Pescara 5
Ragusa 5
Seoul 5
Totale 18.768
Nome #
Mutazioni somatiche di BRAF in pazienti affetti da melanoma maligno metastatico ed efficacia clinica degli approcci terapeutici a bersaglio molecolare con inibitori di BRAF 438
Neoplasie maligne e benigne associate al melanoma multiplo: coinvolgimento di MITF, PTEN and CDKN2A nella cancerogenesi melanocitaria multipla. 410
Novel PTCH1 Mutations in Patients with Keratocystic Odontogenic Tumors Screened for Nevoid Basal Cell Carcinoma (NBCC) Syndrome. 265
The value of fluorimetry (Qubit) and spectrophotometry (NanoDrop) in the quantification of cell-free DNA (cfDNA) in malignant melanoma and prostate cancer patients 255
Wnt pathway, angiogenetic and hormonal markers in sporadic and familial adenomatous polyposis-associated juvenile nasopharyngeal angiofibromas (JNA) 249
Seminal Cell-Free DNA Assessment as a Novel Prostate Cancer Biomarker 240
Diagnostic and pathogenetic role of café-au-lait macules in nevoid basal cell carcinoma syndrome 237
Non-blood sources of cell-free DNA for cancer molecular profiling in clinical pathology and oncology 235
Brooke-Spiegler syndrome tumor spectrum beyond the skin: a patient carrying germline R936X CYLD mutation and a somatic CYLD mutation in Brenner tumor 232
BRAF ,NRASandC-KITAdvanced Melanoma: Clinico-pathological Features, Targeted-Therapy Strategies and Survival 232
Giant elephantiasis neuromatosa in the setting of neurofibromatosis type 1: A case report 225
PTCH1 germline mutations and the basaloid follicular hamartoma values in the tumor spectrum of basal cell carcinoma syndrome (NBCCS) 223
Brooke-Spiegler syndrome: report of two cases not associated with a mutation in the CYLD and PTCH tumor-suppressor genes. 221
"Collision" metastasis from unknown primary squamous cell carcinoma and papillary microcarcinoma of thyroid presenting as lateral cervical cystic mass 220
Hereditary trichilemmal cysts: a proposal for the assessment of diagnostic clinical criteria 219
Grey-blue regression in melanoma in situ-evaluation on 111 cases. 218
Hypomelanosis of Ito with a trisomy 2 mosaicism: a case report 214
Muir-Torre syndrome or phenocopy? The value of the immunohistochemical expression of mismatch repair proteins in sebaceous tumors of immunocompromised patients 214
Mismatch repair genes founder mutations and cancer susceptibility in Lynch syndrome 214
Quick assessment of cell-free DNA in seminal fluid and fragment size for early non-invasive prostate cancer diagnosis 211
Molecular Targeted Approaches for Advanced BRAF V600, N-RAS, c-KIT, and GNAQ Melanomas 208
Confocal microscopy characterization of BRAFV600E mutated melanomas 208
Reticular grey-blue areas of regression as a dermoscopic marker of melanoma in situ. 205
Fordyce granules and hyperplastic mucosal sebaceous glands as distinctive stigmata in Muir-Torre syndrome patients: characterization with reflectance confocal microscopy 202
Skeletal and cranio-facial signs in Gorlin syndrome from ancient Egypt to the modern age: Sphenoid asymmetry in a patient with a novel PTCH1 mutation 201
M09Quantification of circulating cell-free DNA by fluorimetry (Qubit) and spectrophotometry (NanoDrop) in patients with malignant melanoma and prostate cancer 201
Congenital Glioblastoma multiforme and eruptive disseminated Spitz nevi 200
Ameloblastoma: a neglected criterion for nevoid basal cell carcinoma (Gorlin) syndrome. 198
Value of MLH1 and MSH2 mutations in the appearance of Muir-Torre syndrome phenotype in HNPCC patients presenting sebaceous gland tumors or Keratoacanthomas 197
BRAFp.V600E, p.V600K, and p.V600R Mutations in Malignant Melanoma: Do They Also Differ in Immunohistochemical Assessment and Clinical Features? 196
Fluorescence in-situ hybridization and dermoscopy in the assessment of controversial melanocytic tumors. 195
Fibroepithelioma of Pinkus: Solitary tumor or sign of a complex gastrointestinal syndrome 195
Relationship between MUC5AC and altered expression of MLH1 protein in mucinous and non-mucinous colorectal carcinomas 194
A novel CYLD germline mutation in Brooke-Spiegler syndrome. 193
Mismatch Repair Gene Deficiency and Genetic Anticipation in Lynch Syndrome 192
Cancer-associated genodermatoses: Skin neoplasms as clues to hereditary tumor syndromes. 191
Multiphoton laser tomography and fluorescence lifetime imaging of melanoma: morphologic features and quantitative data for sensitive and specific non-invasive diagnostics. 191
Seminal cell free DNA concentration levels discriminate between prostate cancer and benign prostatic hyperplasia 191
Different phenotypes in Muir-Torre Syndrome: clinical and biomolecular characterization in two italian families 190
Desmoplastic melanoma: a challenge for the oncologist 189
NF1 truncating mutations associated to aggressive clinical phenotype with elephantiasis neuromatosa and solid malignancies 189
Aetiology of colorectal cancer and relevance of monogenic inheritance. 188
Attitude of the Italian general population towards prevention and screening of the most common tumors, with special emphasis on colorectal malignancies. 188
Can noninvasive imaging tools potentially predict the risk of ulceration in invasive melanomas showing blue and black colors? 188
Role of microsatellite instability, immunohistochemistry and Mismatch Repair germline aberrations in immunosuppressed transplant patients: a phenocopy dilemma in Muir-Torre Syndrome. 187
p16 immunohistochemistry of multiple primary melanomas as screening to identify Familial Melanoma Syndrome 187
Trend of incidence, subsite distribution and staging of colorectal neoplasms in the 15-year experience of a specialised cancer registry. 186
Dermoscopy of small melanomas: just a miniaturized dermoscopy? 185
High Magnification Digital Dermoscopy of Basal Cell Carcinoma: A Single-centre Study on 400 cases. 184
L'immunoistochimica delle proteine del mismatch repair può essere un utile test per identificare i pazienti HNPCC? 184
Overwhelming response to Dabrafenib in a patient with double BRAF mutation (V600E; V600M) metastatic malignant melanoma 181
Wall paintings facies and their possible genetic correlates in the ancient Pompeii: A bio-anthropologic message from the past? 181
Stem cell properties in cell cultures from different stage of melanoma progression. 181
Cytogenetic abnormalities and clinical features in a patient cohort affected by three or more synchronous or metachronous primitive malignancies. 181
A mononucleotide markers panel to identify hMLH1/hMSH2 germline mutations. 178
Attenuated familial adenomatous polyposis and Muir-Torre syndrome linked to compound biallelic constitutional MYH gene mutations. 178
Microsatellite instability and colorectal cancer prognosis. 177
Value and prognostic significance of mitotic rate in a retrospective series of pT1 cutaneous malignant melanoma patients 174
Biomarkers associated with COVID-19 disease progression 174
Oral mucosal stigmata in hereditary-cancer syndromes: From germline mutations to distinctive clinical phenotypes and tailored therapies 171
Clinical utility gene card for: Gorlin syndrome - update 2013. 170
Leser-Trélat syndrome in patients affected by six multiple metachronous primitive cancers. 167
The dermoscopic variability of pigment network in melanoma in situ. 167
BRAF mutations in multiple sebaceous hyperplasias of patients belonging to MYH-asociated polyposis pedigrees 167
Skeletal stigmata as keys to access to the composite and ancient Gorlin-Goltz syndrome history: The Egypt, Pompeii and Herculaneum lessons 167
The somatic affairs of BRAF: tailored therapies for advanced malignant melanoma and orphan non-V600E (V600R-M) mutations. 166
Seminal cell-free DNA assessment as a novel prostate cancer biomarker 164
Clinico-pathological and biomolecular findings in Italian patients with multiple cutaneous neurofibromas. 162
Molecular genetic alterations and clinical features in early-onset colorectal carcinomas and their role for the recognition of hereditary cancer syndromes. 162
Malignant melanoma in patients with hereditary nonpolyposis colorectal cancer 160
Italian Euromelanoma Day Screening Campaign (2005-2007) and the planning of melanoma screening strategies. 157
High-resolution imaging of basal cell carcinoma: a comparison between multiphoton microscopy with fluorescence lifetime imaging and reflectance confocal microscopy. 157
Giuseppe Moscati (1880-1927): a holistic approach to medicine 156
Variegated Dermoscopy of in situ Melanoma. 155
Quantification of circulating cell-free DNA by fluorimetry (Qubit) and spectrophotometry (NanoDrop) in patients with malignant melanoma and prostate cancer 155
Complete pathological response in a patient with multiple liver metastases from colon cancer treated with Folfox-6 chemotherapy plus bevacizumab: a case report 154
Immunohistochemical expression of MYH protein can be used to identify patients with MYH-associated polyposis 154
Is confocal microscopy a valuable tool in diagnosing nodular lesions? A study on 140 cases. 153
Incidence and survival of patients with Dukes' A (stages T1 and T2) colorectal carcinoma: a 15-year population-based study. 153
Seminal cell-free DNA molecular profile as a novel diagnostic and prognostic prostate cancer biomarkers 152
Patched homolog 1 gene mutation (p.G1093R) induces nevoid basal cell carcinoma syndrome and non-syndromic keratocystic odontogenic tumors: A case report. 152
Gastrointestinal stromal tumor and other primary metachronous and synchronous neoplasms as a suspicious criterion for syndromic setting 151
Microsatellite instability, immunohistochemistry and germline mismatch repair gene mutations for the diagnosis of Muir-Torre syndrome in immunosuppressed patients 151
Proteomic Analysis of PTCH1+/- Fibroblast Lysate and Conditioned Culture Media Isolated from the Skin of Healthy Subjects and Nevoid Basal Cell Carcinoma Syndrome Patients. 151
Diagnosis of BCC by multiphoton laser tomography. 148
Genetic testing among high-risk individuals in families with hereditary non polyposis colorectal cancer 148
Frequency of constitutional MSH6 mutations in a consecutive series of families with clinical suspicion of HNPCC. 147
High resolution diagnosis of common nevi by multiphoton laser tomography and fluorescence lifetime imaging. 146
Diagnosis of hereditary non-polyposis colorectal cancer (HNPCC) [2] (multiple letters) 145
Unicystic ameloblastoma associated with the novel K729M PTCH1 mutation in a patient with nevoid basal cell carcinoma (Gorlin) syndrome. 144
Multiphoton laser tomography and fluorescence lifetime imaging of basal cell carcinoma: morphologic features for non-invasive diagnostics 144
Quantitative evaluation of healthy epidermis by means of multiphoton microscopy and fluorescence lifetime imaging microscopy 144
Distinctive clinical and dermoscopic features of BRAFp.V600K mutated melanomas. 143
Prognostic significance of histological features and biological parameters in stage I (pT1 and pT2) colorectal adenocarcinoma 140
The impact of histopathologic diagnosis on the proper management of testis neoplasms. 139
Multiple primary melanomas versus single melanoma of the head and neck: a comparison of genetic, diagnostic, and therapeutic implications 136
Genotype-phenotype correlations in individuals with a founder mutation in the MLH1 gene and hereditary non-polyposis colorectal cancer 135
Muir-Torre Syndrome and founder Mismatch Repair genes mutations: A long gone historical genetic challenge 133
Epidemiology of colorectal cancer: the 21-year experience of a specialised registry. 133
Microsatellite Instability and Mismatch Repair protein expression in Sebaceous tumors, Keratocanthoma and Basal Cell Carcinomas with sebaceous differentiation in Muir-Torre Syndrome. 132
Totale 18.611
Categoria #
all - tutte 89.579
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.579


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019641 0 0 0 0 0 0 0 0 0 0 0 641
2019/20206.248 487 222 187 330 660 894 1.039 816 809 217 403 184
2020/20215.065 608 167 482 421 656 347 428 567 224 537 289 339
2021/20223.306 260 412 347 182 73 176 175 184 360 238 553 346
2022/20232.776 357 345 210 236 329 383 59 255 316 51 133 102
2023/20241.764 86 90 129 174 383 193 193 216 53 48 100 99
Totale 23.955